The UK Anti-Doping Limited ("UKAD") appeals against the desicon of the UK Antii-Doping Panel dated November 27, 2012. In this decision Ryan Llewellyn (the "Athlete") received an award of one year ineligibility for the use of the prohibited substance Methylhexaneamine, (“MHA”).
Issues at the hearing
The appeal committee is surprised that the UKAD makes a distinction between the use of a specified substance out-of-competition or in-competition.
It has to be determined if the specified prohibited substance was taken to enhance sport performance.
Decision
1. The UKAD's appeal is dismissed
2. An appeal can be made by the relevant international federation or by WADA by appeal to CAS.
